Wen-Feng Chu (Wenfeng Chu)

Years Active: 2018-2020
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Fang Qiu, Yanna Han, Xiaoqi Shao, Petro Paulo, Wenyue Li, Mengying Zhu, Nannan Tang, Shuaili Guo, Yibing Chen, Han Wu, Dan Zhao, Yu Liu, Wen-Feng Chu
Knockdown of endogenous RNF4 exacerbates ischaemia-induced cardiomyocyte apoptosis in mice. Journal of cellular and molecular medicine 24 (17) (2020)
Yu Liu, Jia-Xin Wang, Di Huang, Bing Wang, Liang-Liang Li, Xiu-Xian Li, Ping Ni, Xing-Li Dong, Wei Xia, Chun-Xiao Yu, Wan-Lu Xu, Wen-Feng Chu, Dan Zhao
PMLIV overexpression promotes TGF-β-associated epithelial-mesenchymal transition and migration in MCF-7 cancer cells. Journal of cellular physiology 233 (12) (2018)
Di Wu, Di Huang, Liang-Liang Li, Ping Ni, Xiu-Xian Li, Bing Wang, Yan-Na Han, Xiao-Qi Shao, Dan Zhao, Wen-Feng Chu, Bai-Yan Li
TGF-β1-PML SUMOylation-peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1) form a positive feedback loop to regulate cardiac fibrosis. Journal of cellular physiology 234 (5) (2018)
Siming Yu, Linna Li, Wei Tian, Dan Nie, Wei Mu, Fang Qiu, Yu Liu, Xinghan Liu, Xiaofeng Wang, Zhimin Du, Wen-Feng Chu, Baofeng Yang
PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition. British journal of pharmacology 175 (15) (2018)

Wen-Feng Chu.css-eqlu8i{font-size:small;padding-left:4px;} (Wenfeng Chu)